Community ACS Initiative Reduced EMS Use

• by Andrea Surnit

• May 11, 2026

FDA Approves First Oral PCSK9 Inhibitor

Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.

• by Kathryn Wighton

• July 16, 2026

• 2 min

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.

• by Andrea Surnit

• June 23, 2026

• 4 min

Remembering Past President Ido Weinberg, MD, MSc, MHA, FSVM (1976–2026)

• by Gaurav Parmar, Herbert D Aronow, Mark A Creager, Andrew Dicks, Michael Jaff, Yogendra Kanthi, Raghu Kolluri, Vladimir Lakhter, Elizabeth V Ratchford, Robert Schainfeld, Sneha Thomas, Mitchell D Weinberg, Esther SH Kim

• June 23, 2026